questionText: To ask the Secretary of State for Health and Social Care, which projects using NHS data undertaken by (a) Novartis, (b) IQVIA, (c) AstraZeneca, (d) Merck, (e) Novo Nordisk, (f) GSK, (g) Roche and (h) Janssen-Cilag have adopted the (i) no value sharing, (i
answerText: The Department and the National Health Service in England are moving to a system of “data access as default” for secondary uses of NHS data, which is being supported by the implementation of Secure Data Environments (SDEs). This means that NHS data is inc...
heading: NHS: Medical Records